Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer...
Main Authors: | Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A |
---|---|
מחברים אחרים: | International College of Geriatric Psychoneuropharmacology |
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
John Wiley & Sons, Ltd.
2010
|
נושאים: |
פריטים דומים
-
Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
מאת: Oulhaj, A, et al.
יצא לאור: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
מאת: Smith, A, et al.
יצא לאור: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
מאת: de Jager, C, et al.
יצא לאור: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
מאת: De Jager, C, et al.
יצא לאור: (2012) -
Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
מאת: Goodwin, G
יצא לאור: (2003)